Ofer Goldberg
Pharma
clal Biotechnology industries
Israel
Biography
Ofer Goldberg is the CTO of Clal Biotechnology industries (TASE: CBI) and the managing director of Anatomy Medical Technology Fund. Over the past fifteen years, Mr. Goldberg is actively involved with healthcare related companies ranging in stage from inception to commercialization. Mr. Goldberg serves as a board member in several biotech and medical device companies, including Biocancell (TASE: BNCL), Curetech, Pi-Cardia, Cologuard and SightDX. Mr. Goldberg holds an M.A. in Economics and Finance from Tel Aviv University and a B.Sc. in Physics and Mathematics from the Hebrew University of Jerusalem.
Research Interest
Healthcare
